Close Menu

Data, Manipulated

The US Food and Drug Administration says some data from early testing of Novartis' Zolgensma (onasemnogene abeparvovec-xioi) was manipulated, but the agency says the gene therapy should remain on the market, Reuters reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.